Chander Jagdish, Kaistha Neelam, Gupta Varsha, Mehta Manjula, Singla Nidhi, Deep Antariksh, Sarkar B L
Department of Microbiology, Government Medical College Hospital, Chandigarh, India.
Indian J Med Res. 2009 May;129(5):613-7.
BACKGROUND & OBJECTIVE: Cholera is endemic in Chandigarh and its surrounding areas. This retrospective study was undertaken over a period of nine years (January 1999-December 2007) from a tertiary care hospital in north India to understand the changing epidemiology aspects and antibiotic resistance patterns in Vibrio cholerae isolates.
A total of 277 isolates of V. cholerae were included in the study. V. cholerae was identified by standard microbiological procedures. Antibiotic sensitivity testing was performed by disc diffusion method and isolates phage typed.
All the isolates were identified as V. cholerae O1 biotype El Tor serotype Ogawa; phage 27 was the predominant type. Men were more commonly affected with maximum number in the age group 0-5 yr. Majority of the isolates were resistant to furazolidone but sensitive to gentamicin and cefotaxime. Resistance pattern to amoxycillin was variable. Three isolates were found to be resistant to ciprofloxacin. All the patients presented during June-October coinciding with the monsoon season and a majority were from suburbs.
INTERPRETATION & CONCLUSION: The emergence of resistance amongst V. cholerae especially towards ciprofloxacin may significantly influence the control strategies in future outbreaks. Phage 27 remained the predominant type in all the years. Continuous surveillance with regard to drug resistance, early detection and a strong regional commitment may help contain the disease.
霍乱在昌迪加尔及其周边地区呈地方流行性。本回顾性研究在印度北部一家三级护理医院开展,为期九年(1999年1月至2007年12月),以了解霍乱弧菌分离株流行病学特征的变化及抗生素耐药模式。
本研究共纳入277株霍乱弧菌分离株。通过标准微生物学程序鉴定霍乱弧菌。采用纸片扩散法进行抗生素敏感性试验,并对分离株进行噬菌体分型。
所有分离株均鉴定为霍乱弧菌O1生物型埃尔托型小川血清型;噬菌体27型为主要类型。男性更易感染,0至5岁年龄组感染人数最多。大多数分离株对呋喃唑酮耐药,但对庆大霉素和头孢噻肟敏感。阿莫西林的耐药模式不一。发现三株分离株对环丙沙星耐药。所有患者均在6月至10月就诊,与季风季节一致,且大多数来自郊区。
霍乱弧菌尤其是对环丙沙星耐药性的出现可能会显著影响未来疫情的控制策略。噬菌体27型多年来一直是主要类型。持续监测耐药性、早期发现以及强有力的地区承诺可能有助于控制该疾病。